Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Says New GRMPs Will Shift Drug Review Workload To Earlier In Cycle

Executive Summary

Sponsors and FDA reviewers will have to adjust to the workload of a drug review shifting earlier in the review cycle as the agency implements Good Review Management Principles, now renamed the "21 Century Review Process.

You may also be interested in...



The Good Old Days: FDA's Jenkins Instructs Reviewers To Meet Original User Fee Review Time Standard

Office of New Drugs Director instructs FDA reviewers to return to the practice of meeting 90 percent of their review time goals for new drug applications.

Comparative Effectiveness Reaches Into Drug Reviews, FDA Documents Show

As the health care reform debate focuses on the appropriate role of comparative effectiveness research, a look at FDA’s review practices gives some insight into how the agency already takes the concept into account in its review decisions.

Comparative Effectiveness Reaches Into Drug Reviews, FDA Documents Show

As the health care reform debate focuses on the appropriate role of comparative effectiveness research, a look at FDA’s review practices gives some insight into how the agency already takes the concept into account in its review decisions.

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS050410

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel